Skip to content
Pirouette Pharma logo

Pirouette Pharma

Pirouette Pharma is a YC Summer 2021 (S21) company. Based in Boston, MA, USA. Team of 9.

  • Health Tech
  • Medical Devices
  • Biotech
  • Healthcare

About Pirouette Pharma

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Pirouette Pharma builds OnePush, a disc-shaped, push-button auto-injector with a fully automatic hidden needle, designed for home self-administration of injectable therapies for chronic conditions such as oncology and HIV. The device replaces traditional auto-injectors that require training and expose the needle, removing the hesitation and anxiety that drive non-adherence. Pharmaceutical partners co-develop with Pirouette to place their existing or novel injectables into the OnePush platform, pairing with established FDA data to accelerate development.

Business model

Co-development and platform partnerships with pharmaceutical companies.

Go-to-market

Pharmaceutical companies are the primary partners, licensing or co-developing the OnePush platform to deliver their branded injectables; patients using chronic injectable therapies are the end users the device is designed around.

From the Y Combinator listing

How Pirouette Pharma describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

We make injections as easy as pushing a button!

At Pirouette, we have developed a low-profile, disk-shaped, rugged injection device with a patient-centric focus on affordability, portability, and usability. The patented device, based on extensive patient input, is designed to make administering an injection as easy as pushing a button. This allows individuals with limited or no training to easily and intuitively perform an injection on themselves or others.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
Boston, MA, USA
Team size
9
Status
Active
Stage
Growth

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works